Compound information
- Natural Products
- ZC337752
- Molecular Formula
- C11H15ClN2O4S
- Molecular Weight
- 306.04410564 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-[3-(dimethylsulfamoyl)-4-methoxy-phenyl]acetamide
- InChI
- InChI=1S/C11H15ClN2O4S/c1-14(2)19(16,17)10-6-8(13-11(15)7-12)4-5-9(10)18-3/h4-6H,7H2,1-3H3,(H,13,15)
- InChI Key
- LDKUUMITLKKHFM-UHFFFAOYSA-N
- SMILES
- COc1ccc(NC(=O)CCl)cc1S(=O)(=O)N(C)C
- Source
- ZINC000008037256
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 75.71 Å2 | LogP | 1.059 |
LogS | -2.702 | LogD | 1.068 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.047 | Pgp substrate | 0.148 |
HIA | 0.956 | F20 % | 0.985 |
F30 % | 0.866 | Caco-2 | -5.354 |
MDCK | -5.706 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.14 | PPB | 97.15 |
VD | 0.799 | Fu | 0.69 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.588 | CYP1A2 substrate | 0.671 |
CYP2A6 substrate | 0.764 | CYP2B6 substrate | 0.637 |
CYP2C19 inhibitor | 0.379 | CYP2C19 substrate | 0.883 |
CYP2C8 substrate | 0.863 | CYP2C9 inhibitor | 0.064 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.015 |
CYP2D6 substrate | 0.929 | CYP2E1 substrate | 0.892 |
CYP3A4 inhibitor | 0.204 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.549 | CL | 10.783 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.175 | Hepatotoxicity | 0.941 |
Mutagenicity | 0.019 | Rat Oral Acute Toxicity | 0.12 |
FDAMDD | 0.087 | Skin Sensitization | 0.987 |
Carcinogenicity | 0.463 | Eye Corrosion | 0.069 |
Eye Irritation | 0.061 | Respiratory Toxicity | 0.975 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.498 | IGC50 | 3.411 |
LC50FM | 3.839 | LC50DM | 3.29 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.15 | NR-AR-LBD | 0.4 |
NR-AhR | 0.716 | NR-Aromatase | 0.669 |
NR-ER | 0.376 | NR-ER-LBD | 0.548 |
NR-PPAR-gamma | 0.893 | SR-ARE | 0.974 |
SR-ATAD5 | 0.638 | SR-HSE | 0.897 |
SR-MMP | 0.331 | SR-p53 | 0.891 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.